Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	89098
Country	China

Received	2023-10-21 01:34
Peer-Review Started	2023-10-21 01:35
To Make the First Decision
Return for Revision	2023-11-07 02:23
Revised	2023-11-14 02:25
Second Decision	2023-12-06 02:41
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-12-06 05:41
Articles in Press	2023-12-06 05:41
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-04 02:38
Publish the Manuscript Online	2024-01-11 06:17

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Present situation and prospect of immunotherapy for unresectable locally advanced esophageal cancer during peri-radiotherapy
Manuscript Source	Invited Manuscript
All Author List	Feng-Mei Wang, Peng Mo, Xue Yan, Xin-Yue Lin and Zhi-Chao Fu
ORCID	Author(s) ORCID Number Zhi-Chao Fu http://orcid.org/0000-0001-8096-3496
Funding Agency and Grant Number	Funding Agency Grant Number Natural Science Foundation of Fujian Province No. 2021J011259
Corresponding Author	Zhi-Chao Fu, MD, PhD, Doctor, Department of Radiotherapy, Fuzong Clinical Medical College (900th Hospital), Fujian Medical University, No. 156 West Second Ring Road North, Fuzhou 350025, Fujian Province, China. fauster1112@126.com
Key Words	Esophageal carcinoma; Locally advanced; Radiotherapy; Immunotherapy
Core Tip	For unresectable or inoperable non-metastatic esophageal cancer, concurrent radiotherapy and chemotherapy is the standard treatment recommended by various guidelines. Because its curative effect is still not ideal, it is still necessary to explore radical radiotherapy and chemotherapy in the future, and it is considered to be very promising to combine with immune drugs represented by anti-programmed death protein-1. This paper mainly discusses how to combine radical concurrent radiotherapy and chemotherapy with immunotherapy for unresectable local late esophageal cancer.
Publish Date	2024-01-11 06:17
Citation	Wang FM, Mo P, Yan X, Lin XY, Fu ZC. Present situation and prospect of immunotherapy for unresectable locally advanced esophageal cancer during peri-radiotherapy. World J Gastrointest Oncol 2024; 16(1): 1-7
URL	https://www.wjgnet.com/1948-5204/full/v16/i1/1.htm
DOI	https://dx.doi.org/10.4251/wjgo.v16.i1.1

Full Article (PDF)	WJGO-16-1-with-cover.pdf
Full Article (Word)	WJGO-16-1.docx
Manuscript File	89098_Auto_Edited-JLW.docx
Answering Reviewers	89098-Answering reviewers.pdf
Audio Core Tip	89098-Audio core tip.wav
Conflict-of-Interest Disclosure Form	89098-Conflict-of-interest statement.pdf
Copyright License Agreement	89098-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	89098-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	89098-Language certificate.pdf
Peer-review Report	89098-Peer-review(s).pdf
Scientific Misconduct Check	89098-Bing-Qu XL-2.jpg
Scientific Editor Work List	89098-Scientific editor work list.pdf